Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Exploring the Role of a Novel Tumor Suppressor - OSR2 in T-ALL

Arpan A. Sinha, MBBS, MD, Pilar I. Andrade, MS, Megan Malone-Perez, BS, Syed T Ahmed, MD, J. Kimble Frazer, MD PhD

Blood (2020) 136 (Supplement 1): 26.

https://doi.org/10.1182/blood-2020-142772

Published: 2020

Journal Articles

Characteristics, Social Factors, and Trends in HIV and AIDS-Related Lymphoma: A 23-Year Analysis Since the Implementation of c ART, a County Hospital AIDS Malignancy Project (CHAMP) Study

Camille E. Demarco, MPH, Pei Lu, MD, David F. Peace, Sunny Singh, MD, Dennis F. Angelov, Kelly A. Benante, MPH, Ahmed T. Ahmed, MD, Paul G. Rubinstein, MD

Blood (2018) 132 (Supplement 1): 2304.

https://doi.org/10.1182/blood-2018-99-117391

Published: 2018

Journal Articles

The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase

W Xu, K Seiter, E Feldman, T Ahmed, JW Chiao

Blood (1996) 87 (11): 4502–4506.

https://doi.org/10.1182/blood.V87.11.4502.bloodjournal87114502

Published: 1996

Journal Articles

Cure in acute promyelocytic leukemia: now more readily achievable with less toxic therapy [letter]

ZA Arlin, T Ahmed

Blood (1992) 79 (9): 2492–2494.

https://doi.org/10.1182/blood.V79.9.2492.bloodjournal7992492b

Published: 1992

Journal Articles

Microenvironmental toxicity of azidothymidine: partial sparing with hemin

NG Abraham, D Bucher, U Niranjan, AC Brown, JD Lutton, A Distenfeld, T Ahmed, RD Levere

Blood (1989) 74 (1): 139–144.

https://doi.org/10.1182/blood.V74.1.139.139

Published: 1989

Journal Articles

Amsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adults

ZA Arlin, E Feldman, S Kempin, T Ahmed, A Mittelman, S Savona, J Ascensao, P Baskind, P Sullivan, HG Fuhr

Blood (1988) 72 (2): 433–435.

https://doi.org/10.1182/blood.V72.2.433.433

Published: 1988

NARROW

Exploring the Role of a Novel Tumor Suppressor - OSR2 in T-ALL

Characteristics, Social Factors, and Trends in HIV and AIDS-Related Lymphoma: A 23-Year Analysis Since the Implementation of c ART, a County Hospital AIDS Malignancy Project (CHAMP) Study

The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase

Cure in acute promyelocytic leukemia: now more readily achievable with less toxic therapy [letter]

Microenvironmental toxicity of azidothymidine: partial sparing with hemin

Amsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adults

Email alerts

ASH Publications

American Society of Hematology

Exploring the Role of a Novel Tumor Suppressor - OSR2 in T-ALL

Characteristics, Social Factors, and Trends in HIV and AIDS-Related Lymphoma: A 23-Year Analysis Since the Implementation of c ART, a County Hospital AIDS Malignancy Project (CHAMP) Study

The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase

Cure in acute promyelocytic leukemia: now more readily achievable with less toxic therapy [letter]

Microenvironmental toxicity of azidothymidine: partial sparing with hemin

Amsacrine with high-dose cytarabine is highly effective therapy for refractory and relapsed acute lymphoblastic leukemia in adults

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only